Yang Yang, Chu Chenyu, Xiao Wenlan, Liu Li, Man Yi, Lin Jie, Qu Yili
Department of Oral Implantology & Department of Prosthodontics & State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, People's Republic of China.
State Key Laboratory of Biotherapy and Laboratory, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Sichuan University, Chengdu 610041, People's Republic of China.
Biomed Mater. 2022 Feb 28;17(2). doi: 10.1088/1748-605X/ac5572.
The usage of bone substitute granule materials has improved the clinical results of alveolar bone deficiencies treatment and thus broadened applications in implant dentistry. However, because of the complicated mechanisms controlling the foreign body response, no perfect solution can avoid the fibrotic encapsulation of materials till now, which may impair the results of bone regeneration, even cause the implant materials rejection. Recently, the concept of 'osteoimmunology' has been stressed. The outcomes of bone regeneration are proved to be related to the bio-physicochemical properties of biomaterials, which allow them to regulate the biological behaviours of both innate and adaptive immune cells. With the development of single cell transcriptome, the truly heterogeneity of osteo-immune cells has been clarifying, which is helpful to overcome the limitations of traditional M1/M2 macrophage nomenclature and drive the advancements of particulate biomaterials applications. This review aims at introducing the mechanisms of optimal osseointegration regulated by immune systems and provides feasible strategies for the design of next generation 'osteoimmune-smart' particulate bone substitute materials in dental clinic.
骨替代颗粒材料的应用改善了牙槽骨缺损治疗的临床效果,从而拓宽了其在种植牙科中的应用。然而,由于控制异物反应的机制复杂,迄今为止尚无完美的解决方案能够避免材料的纤维化包裹,这可能会损害骨再生的效果,甚至导致植入材料排斥反应。最近,“骨免疫学”的概念受到了重视。骨再生的结果被证明与生物材料的生物物理化学性质有关,这些性质使它们能够调节先天免疫细胞和适应性免疫细胞的生物学行为。随着单细胞转录组学的发展,骨免疫细胞真正的异质性正在逐渐明晰,这有助于克服传统M1/M2巨噬细胞命名法的局限性,并推动颗粒生物材料应用的进展。本综述旨在介绍免疫系统调节最佳骨整合的机制,并为牙科临床中下一代“骨免疫智能”颗粒骨替代材料的设计提供可行策略。